|
JPH1050306A
(ja)
*
|
1996-07-31 |
1998-02-20 |
Toyota Autom Loom Works Ltd |
水素吸蔵合金電極の製造方法
|
|
BE1011045A3
(fr)
*
|
1997-03-14 |
1999-04-06 |
Ucb Sa |
Compositions pharmaceutiques pour la liberation controlee de substances actives.
|
|
US20050085498A1
(en)
*
|
1998-05-28 |
2005-04-21 |
Byrd Edward A. |
Oral formulation of lipid soluble thiamine, lipoic acid, creatine derivative, and L-arginine alpha-ketoglutarate
|
|
EP2266542A3
(en)
*
|
1998-10-01 |
2013-07-31 |
Elan Pharma International Limited |
Controlled release nanoparticulate compositions
|
|
JP2001107258A
(ja)
*
|
1999-10-06 |
2001-04-17 |
Hitachi Ltd |
無電解銅めっき方法とめっき装置および多層配線基板
|
|
US10179130B2
(en)
|
1999-10-29 |
2019-01-15 |
Purdue Pharma L.P. |
Controlled release hydrocodone formulations
|
|
KR100889069B1
(ko)
|
1999-10-29 |
2009-03-17 |
유로-셀티크 소시에떼 아노뉨 |
서방성 하이드로코돈 제형
|
|
EP1118321A1
(fr)
*
|
2000-01-14 |
2001-07-25 |
Ucb, S.A. |
Compositions pharmaceutiques solides pour la libération contrôlée de substances actives
|
|
US6242003B1
(en)
|
2000-04-13 |
2001-06-05 |
Novartis Ag |
Organic compounds
|
|
GB0009522D0
(en)
*
|
2000-04-19 |
2000-06-07 |
Smithkline Beecham Plc |
Composition
|
|
AU2738302A
(en)
*
|
2000-10-30 |
2002-05-15 |
Euro Celtique Sa |
Controlled release hydrocodone formulations
|
|
US20060127474A1
(en)
|
2001-04-11 |
2006-06-15 |
Oskar Kalb |
Pharmaceutical compositions comprising fluvastatin
|
|
ATE432068T1
(de)
*
|
2001-06-28 |
2009-06-15 |
Ucb Farchim Sa |
Cetirizin und pseudoephedrin enthaltende tablette
|
|
US7014867B2
(en)
|
2001-06-28 |
2006-03-21 |
Ucb Farchim Sa |
Tablet comprising cetirizine and pseudoephedrine
|
|
US20030092724A1
(en)
*
|
2001-09-18 |
2003-05-15 |
Huaihung Kao |
Combination sustained release-immediate release oral dosage forms with an opioid analgesic and a non-opioid analgesic
|
|
EP1465607B1
(fr)
*
|
2002-01-09 |
2007-03-21 |
UCB Farchim S.A. |
Compositions pharmaceutiques a liberation modifiee
|
|
ATE388693T1
(de)
*
|
2002-04-04 |
2008-03-15 |
Pfizer Prod Inc |
Wohlschmeckende kautablette
|
|
US20050020613A1
(en)
*
|
2002-09-20 |
2005-01-27 |
Alpharma, Inc. |
Sustained release opioid formulations and method of use
|
|
US8487002B2
(en)
*
|
2002-10-25 |
2013-07-16 |
Paladin Labs Inc. |
Controlled-release compositions
|
|
TWI319713B
(en)
*
|
2002-10-25 |
2010-01-21 |
|
Sustained-release tramadol formulations with 24-hour efficacy
|
|
DE60322577D1
(de)
*
|
2002-12-06 |
2008-09-11 |
Ucb Farchim Sa |
Tablette enthaltend efletirizin und pseudoephedrin
|
|
US20060172006A1
(en)
*
|
2003-10-10 |
2006-08-03 |
Vincent Lenaerts |
Sustained-release tramadol formulations with 24-hour clinical efficacy
|
|
US20050266032A1
(en)
*
|
2003-12-17 |
2005-12-01 |
Sovereign Pharmaceuticals, Ltd. |
Dosage form containing multiple drugs
|
|
US20050232987A1
(en)
*
|
2004-03-12 |
2005-10-20 |
Viswanathan Srinivasan |
Dosage form containing a morphine derivative and another drug
|
|
US20050232986A1
(en)
*
|
2003-12-17 |
2005-10-20 |
David Brown |
Dosage form containing promethazine and another drug
|
|
US20050281875A1
(en)
*
|
2003-12-17 |
2005-12-22 |
Sovereign Pharmaceuticals, Ltd. |
Promethazine containing dosage form
|
|
US9492541B2
(en)
*
|
2004-09-14 |
2016-11-15 |
Sovereign Pharmaceuticals, Llc |
Phenylepherine containing dosage form
|
|
US20060029664A1
(en)
*
|
2004-08-04 |
2006-02-09 |
Sovereign Pharmaceuticals, Ltd. |
Dosage form containing carbetapentane and another drug
|
|
US7897172B2
(en)
*
|
2004-05-18 |
2011-03-01 |
L. Perrigo Company |
Tablets exhibiting reduced drug release variability
|
|
US9308164B2
(en)
*
|
2004-06-30 |
2016-04-12 |
Sovereign Pharmaceuticals, Llc |
Hyoscyamine dosage form
|
|
WO2006022996A2
(en)
*
|
2004-08-04 |
2006-03-02 |
Sovereign Pharmaceuticals, Ltd. |
Dosage form containing multiple drugs
|
|
US9592197B2
(en)
*
|
2004-12-16 |
2017-03-14 |
Sovereign Pharmaceuticals, Llc |
Dosage form containing diphenhydramine and another drug
|
|
US20070003622A1
(en)
*
|
2004-12-16 |
2007-01-04 |
Sovereign Pharmaceuticals, Ltd. |
Diphenhydramine containing dosage form
|
|
US7529255B2
(en)
*
|
2005-04-21 |
2009-05-05 |
Microsoft Corporation |
Peer-to-peer multicasting using multiple transport protocols
|
|
AU2006274263B2
(en)
*
|
2005-07-26 |
2011-01-27 |
Ucb Pharma, S.A. |
Pharmaceutical compositions comprising levetiracetam and process for their preparation
|
|
PT1931346E
(pt)
*
|
2005-09-09 |
2012-08-14 |
Angelini Labopharm Llc |
Composição de trazodona para administração uma vez por dia
|
|
WO2007048219A2
(en)
|
2005-09-09 |
2007-05-03 |
Labopharm Inc. |
Sustained drug release composition
|
|
KR20080089653A
(ko)
*
|
2006-01-21 |
2008-10-07 |
애보트 게엠베하 운트 콤파니 카게 |
남용 약물의 전달을 위한 투여형 및 방법
|
|
US20100172989A1
(en)
*
|
2006-01-21 |
2010-07-08 |
Abbott Laboratories |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
|
US20090022798A1
(en)
*
|
2007-07-20 |
2009-01-22 |
Abbott Gmbh & Co. Kg |
Formulations of nonopioid and confined opioid analgesics
|
|
US20090317355A1
(en)
*
|
2006-01-21 |
2009-12-24 |
Abbott Gmbh & Co. Kg, |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
|
KR100753480B1
(ko)
*
|
2006-01-27 |
2007-08-31 |
씨제이 주식회사 |
잘토프로펜 함유 서방성 정제 및 그 제조방법
|
|
US20070253927A1
(en)
*
|
2006-04-13 |
2007-11-01 |
Gwenaelle Jegou |
Cosmetic compositions comprising at least one dielectrophile monomer and at least one radical initiator
|
|
WO2007141743A2
(en)
*
|
2006-06-06 |
2007-12-13 |
Ranbaxy Laboratories Limited |
A tablet dosage form comprising cetirizine and pseudoephedrine
|
|
US20080069891A1
(en)
|
2006-09-15 |
2008-03-20 |
Cima Labs, Inc. |
Abuse resistant drug formulation
|
|
CA2657437A1
(en)
*
|
2006-06-19 |
2007-12-27 |
Accu-Break Technologies, Inc. |
Segmented pharmaceutical dosage forms
|
|
US8765178B2
(en)
*
|
2006-07-19 |
2014-07-01 |
Watson Laboratories, Inc. |
Controlled release formulations and associated methods
|
|
US8445018B2
(en)
|
2006-09-15 |
2013-05-21 |
Cima Labs Inc. |
Abuse resistant drug formulation
|
|
EP2068713B1
(en)
|
2006-09-25 |
2012-07-18 |
Koninklijke Philips Electronics N.V. |
Shifting an object for complete trajectories in rotational x-ray imaging
|
|
SI2124556T1
(sl)
|
2006-10-09 |
2015-01-30 |
Charleston Laboratories, Inc. |
Farmacevtske sestave
|
|
KR20090088913A
(ko)
|
2006-11-21 |
2009-08-20 |
맥네일-피피씨, 인코포레이티드 |
개질된 방출형 진통 현탁제
|
|
US9833510B2
(en)
*
|
2007-06-12 |
2017-12-05 |
Johnson & Johnson Consumer Inc. |
Modified release solid or semi-solid dosage forms
|
|
JP5453280B2
(ja)
*
|
2007-10-16 |
2014-03-26 |
ラボファーム インコーポレイテッド |
アセトアミノフェンおよびトラマドールを持続的に放出するための二層組成物
|
|
US9149429B2
(en)
*
|
2007-11-21 |
2015-10-06 |
The Procter & Gamble Company |
Preparations, methods and kits useful for the treatment of cough
|
|
US8486448B2
(en)
|
2007-12-17 |
2013-07-16 |
Paladin Labs Inc. |
Misuse preventative, controlled release formulation
|
|
EP3090743A1
(en)
|
2008-01-09 |
2016-11-09 |
Charleston Laboratories, Inc. |
Pharmaceutical compositions for treating headache and eliminating nausea
|
|
US9226907B2
(en)
|
2008-02-01 |
2016-01-05 |
Abbvie Inc. |
Extended release hydrocodone acetaminophen and related methods and uses thereof
|
|
ES2509497T3
(es)
|
2008-12-16 |
2014-10-17 |
Paladin Labs Inc. |
Formulación de liberación controlada para evitar un uso indebido
|
|
EP2381937A2
(en)
|
2008-12-31 |
2011-11-02 |
Upsher-Smith Laboratories, Inc. |
Opioid-containing oral pharmaceutical compositions and methods
|
|
CA2767576C
(en)
|
2009-07-08 |
2020-03-10 |
Charleston Laboratories Inc. |
Pharmaceutical compositions comprising an antiemetic and an opioid analgesic
|
|
US9023390B2
(en)
|
2009-09-17 |
2015-05-05 |
Upsher-Smith Laboratories, Inc. |
Sustained-release product comprising a combination of a non-opioid amine and a non-steroidal anti-inflammatory drug
|
|
CA2798702A1
(en)
|
2010-05-11 |
2011-11-17 |
Cima Labs Inc. |
Alcoholresistant metoprolol-containing extended-release oral dosage forms
|
|
CN102302497A
(zh)
*
|
2011-05-18 |
2012-01-04 |
天圣制药集团股份有限公司 |
一种治疗过敏性鼻炎的制剂及其制备方法
|
|
ES2795291T3
(es)
|
2013-02-13 |
2020-11-23 |
Procter & Gamble |
Medicamento con sabor a anís
|
|
KR102070076B1
(ko)
*
|
2013-05-03 |
2020-01-29 |
주식회사 제닉 |
탄산 함유 입자를 포함하는 필름
|
|
US20150118300A1
(en)
|
2013-10-31 |
2015-04-30 |
Cima Labs Inc. |
Immediate Release Abuse-Deterrent Granulated Dosage Forms
|
|
CA2941829C
(en)
|
2014-03-11 |
2021-11-02 |
Redhill Biopharma Ltd |
Ondansetron extended release solid dosage forms for treating either nausea, vomiting or diarrhea symptoms
|
|
CA3055170A1
(en)
|
2016-03-04 |
2017-09-08 |
Charleston Laboratories, Inc. |
Pharmaceutical compositions
|
|
RU2687715C1
(ru)
*
|
2018-05-07 |
2019-05-15 |
Федеральное государственное бюджетное учреждение науки Институт горного дела Дальневосточного отделения Российской академии наук |
Способ комбинированной разработки россыпных месторождений золота
|
|
US12589083B2
(en)
|
2019-05-07 |
2026-03-31 |
Clexio Biosciences Ltd. |
Abuse-deterrent dosage forms containing esketamine
|
|
US11324707B2
(en)
|
2019-05-07 |
2022-05-10 |
Clexio Biosciences Ltd. |
Abuse-deterrent dosage forms containing esketamine
|
|
KR102073185B1
(ko)
*
|
2019-07-16 |
2020-02-04 |
(주)위바이오트리 |
활성성분을 포함하는 변성 다중층 수산화물 구조체를 포함하는 금속 수산화물 복합체 및 이의 제조 방법
|